Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 155

1.

Genetic Predictors of Response to Acupuncture for Aromatase Inhibitor-Associated Arthralgia Among Breast Cancer Survivors.

Genovese TJ, Mao JJ.

Pain Med. 2018 Apr 17. doi: 10.1093/pm/pny067. [Epub ahead of print]

PMID:
29912452
2.

Medical Malpractice Following Carpal Tunnel Surgery.

Gil JA, Bokshan S, Genovese T, Got C, Daniels AH.

Orthopedics. 2018 May 29:1-3. doi: 10.3928/01477447-20180524-05. [Epub ahead of print]

PMID:
29813166
3.

AQX-1125, small molecule SHIP1 activator inhibits bleomycin-induced pulmonary fibrosis.

Cross J, Stenton GR, Harwig C, Szabo C, Genovese T, Di Paola R, Esposito E, Cuzzocrea S, Mackenzie LF.

Br J Pharmacol. 2017 Sep;174(18):3045-3057. doi: 10.1111/bph.13934. Epub 2017 Aug 11.

PMID:
28658529
4.

Subjective anger and overt aggression in psychiatric outpatients.

Genovese T, Dalrymple K, Chelminski I, Zimmerman M.

Compr Psychiatry. 2017 Feb;73:23-30. doi: 10.1016/j.comppsych.2016.10.008. Epub 2016 Oct 17.

PMID:
27855338
5.

Effects of thymosin β4 and its N-terminal fragment Ac-SDKP on TGF-β-treated human lung fibroblasts and in the mouse model of bleomycin-induced lung fibrosis.

Conte E, Iemmolo M, Fruciano M, Fagone E, Gili E, Genovese T, Esposito E, Cuzzocrea S, Vancheri C.

Expert Opin Biol Ther. 2015;15 Suppl 1:S211-21. doi: 10.1517/14712598.2015.1026804. Epub 2015 Jun 22.

PMID:
26098610
6.

Thymosin β4 reduces IL-17-producing cells and IL-17 expression, and protects lungs from damage in bleomycin-treated mice.

Conte E, Iemmolo M, Fagone E, Gili E, Fruciano M, Genovese T, Esposito E, Cuzzocrea S, Vancheri C.

Immunobiology. 2014 Jun;219(6):425-31. doi: 10.1016/j.imbio.2014.02.001. Epub 2014 Feb 14.

PMID:
24613476
7.

Absence of TLR4 reduces neurovascular unit and secondary inflammatory process after traumatic brain injury in mice.

Ahmad A, Crupi R, Campolo M, Genovese T, Esposito E, Cuzzocrea S.

PLoS One. 2013;8(3):e57208. doi: 10.1371/journal.pone.0057208. Epub 2013 Mar 28.

8.

Post-ischaemic thyroid hormone treatment in a rat model of acute stroke.

Genovese T, Impellizzeri D, Ahmad A, Cornelius C, Campolo M, Cuzzocrea S, Esposito E.

Brain Res. 2013 Jun 4;1513:92-102. doi: 10.1016/j.brainres.2013.03.001. Epub 2013 Mar 13.

PMID:
23500636
9.

Thymosin β4 protects C57BL/6 mice from bleomycin-induced damage in the lung.

Conte E, Genovese T, Gili E, Esposito E, Iemmolo M, Fruciano M, Fagone E, Pistorio MP, Crimi N, Cuzzocrea S, Vancheri C.

Eur J Clin Invest. 2013 Mar;43(3):309-15. doi: 10.1111/eci.12048. Epub 2013 Jan 16.

PMID:
23320620
10.

The renal injury and inflammation caused by ischemia-reperfusion are reduced by genetic inhibition of TNF-αR1: a comparison with infliximab treatment.

Di Paola R, Genovese T, Impellizzeri D, Ahmad A, Cuzzocrea S, Esposito E.

Eur J Pharmacol. 2013 Jan 30;700(1-3):134-46. doi: 10.1016/j.ejphar.2012.11.066. Epub 2013 Jan 3.

PMID:
23291313
11.

Reduction of ischemic brain injury by administration of palmitoylethanolamide after transient middle cerebral artery occlusion in rats.

Ahmad A, Genovese T, Impellizzeri D, Crupi R, Velardi E, Marino A, Esposito E, Cuzzocrea S.

Brain Res. 2012 Oct 5;1477:45-58. doi: 10.1016/j.brainres.2012.08.006. Epub 2012 Aug 13.

PMID:
23046519
12.

Protective effects of thymosin β4 in a mouse model of lung fibrosis.

Conte E, Genovese T, Gili E, Esposito E, Iemmolo M, Fruciano M, Fagone E, Pistorio MP, Crimi N, Cuzzocrea S, Vancheri C.

Ann N Y Acad Sci. 2012 Oct;1269:69-73. doi: 10.1111/j.1749-6632.2012.06694.x.

PMID:
23045972
13.

In vitro and in vivo properties of a fully human IgG1 monoclonal antibody that combats multidrug resistant Pseudomonas aeruginosa.

Adawi A, Bisignano C, Genovese T, Filocamo A, Khouri-Assi C, Neville A, Feuerstein GZ, Cuzzocrea S, Neville LF.

Int J Mol Med. 2012 Sep;30(3):455-64. doi: 10.3892/ijmm.2012.1040. Epub 2012 Jun 20.

14.

Recombinant human activated protein C (Xigris) attenuates murine cerulein-induced acute pancreatitis via regulation of nuclear factor κB and apoptotic pathways.

Babu BI, Genovese T, Mazzon E, Riccardi L, Paterniti I, Galuppo M, Crisafulli C, Siriwardena AK, Cuzzocrea S.

Pancreas. 2012 May;41(4):619-28. doi: 10.1097/MPA.0b013e31823ca26d.

PMID:
22441146
15.

Neuroprotective effects of olprinone after cerebral ischemia/reperfusion injury in rats.

Genovese T, Mazzon E, Paterniti I, Esposito E, Cuzzocrea S.

Neurosci Lett. 2011 Oct 3;503(2):93-9. doi: 10.1016/j.neulet.2011.08.015. Epub 2011 Aug 17.

PMID:
21872644
16.

MK801 attenuates secondary injury in a mouse experimental compression model of spinal cord trauma.

Esposito E, Paterniti I, Mazzon E, Genovese T, Galuppo M, Meli R, Bramanti P, Cuzzocrea S.

BMC Neurosci. 2011 Apr 14;12:31. doi: 10.1186/1471-2202-12-31.

17.

Effects of palmitoylethanolamide on release of mast cell peptidases and neurotrophic factors after spinal cord injury.

Esposito E, Paterniti I, Mazzon E, Genovese T, Di Paola R, Galuppo M, Cuzzocrea S.

Brain Behav Immun. 2011 Aug;25(6):1099-112. doi: 10.1016/j.bbi.2011.02.006. Epub 2011 Feb 25.

PMID:
21354467
18.

Natural almond skin reduced oxidative stress and inflammation in an experimental model of inflammatory bowel disease.

Mandalari G, Bisignano C, Genovese T, Mazzon E, Wickham MS, Paterniti I, Cuzzocrea S.

Int Immunopharmacol. 2011 Aug;11(8):915-24. doi: 10.1016/j.intimp.2011.02.003. Epub 2011 Feb 24.

PMID:
21354356
19.

Modulation of NADPH oxidase activation in cerebral ischemia/reperfusion injury in rats.

Genovese T, Mazzon E, Paterniti I, Esposito E, Bramanti P, Cuzzocrea S.

Brain Res. 2011 Feb 4;1372:92-102. doi: 10.1016/j.brainres.2010.11.088. Epub 2010 Dec 4.

PMID:
21138737
20.

Neuroprotective effects of almond skins in experimental spinal cord injury.

Mandalari G, Genovese T, Bisignano C, Mazzon E, Wickham MS, Di Paola R, Bisignano G, Cuzzocrea S.

Clin Nutr. 2011 Apr;30(2):221-33. doi: 10.1016/j.clnu.2010.08.002.

PMID:
20864228
21.

Efficacy of treatment with verbascoside, biotechnologically produced by Syringa vulgaris plant cell cultures in an experimental mice model of spinal cord trauma.

Genovese T, Paterniti I, Mazzon E, Esposito E, Di Paola R, Galuppo M, Bramanti P, Cuzzocrea S.

Naunyn Schmiedebergs Arch Pharmacol. 2010 Oct;382(4):331-45. doi: 10.1007/s00210-010-0537-2. Epub 2010 Aug 27.

PMID:
20799028
22.

GW0742, a high-affinity PPAR -beta/delta agonist, inhibits acute lung injury in mice.

Di Paola R, Crisafulli C, Mazzon E, Esposito E, Paterniti I, Galuppo M, Genovese T, Thiemermann C, Cuzzocrea S.

Shock. 2010 Apr;33(4):426-35. doi: 10.1097/SHK.0b013e3181b8f2fb.

PMID:
20407409
23.

Selective adenosine A(2a) receptor agonists reduce the apoptosis in an experimental model of spinal cord trauma.

Genovese T, Melani A, Esposito E, Paterniti I, Mazzon E, Di Paola R, Bramanti P, Linden J, Pedata F, Cuzzocrea S.

J Biol Regul Homeost Agents. 2010 Jan-Mar;24(1):73-86. Erratum in: J Biol Regul Homeost Agents. 2010 Apr-Jun;24(2):228.

PMID:
20385073
24.

Role of PPAR-delta in the development of zymosan-induced multiple organ failure: an experiment mice study.

Galuppo M, Di Paola R, Mazzon E, Genovese T, Crisafulli C, Paterniti I, Cuzzocrea E, Bramanti P, Kapoor A, Thiemermann C, Cuzzocrea S.

J Inflamm (Lond). 2010 Feb 18;7:12. doi: 10.1186/1476-9255-7-12.

25.

Effect of PD98059, a selective MAPK3/MAPK1 inhibitor, on acute lung injury in mice.

Di Paola R, Crisafulli C, Mazzon E, Genovese T, Paterniti I, Bramanti P, Cuzzocrea S.

Int J Immunopathol Pharmacol. 2009 Oct-Dec;22(4):937-50.

PMID:
20074457
26.

Liver X receptor agonist treatment reduced splanchnic ischemia and reperfusion injury.

Crisafulli C, Di Paola R, Mazzon E, Paterniti I, Galuppo M, Genovese T, Bramanti P, Cappellani A, Cuzzocrea S.

J Leukoc Biol. 2010 Feb;87(2):309-21. doi: 10.1189/jlb.0609438. Epub 2009 Dec 22.

PMID:
20028773
27.

Liver X receptor agonist treatment regulates inflammatory response after spinal cord trauma.

Paterniti I, Genovese T, Mazzon E, Crisafulli C, Di Paola R, Galuppo M, Bramanti P, Cuzzocrea S.

J Neurochem. 2010 Feb;112(3):611-24. doi: 10.1111/j.1471-4159.2009.06471.x. Epub 2009 Nov 4.

28.

PPAR-alpha contributes to the anti-inflammatory activity of 17beta-estradiol.

Crisafulli C, Bruscoli S, Esposito E, Mazzon E, Di Paola R, Genovese T, Bramanti P, Migliorati G, Cuzzocrea S.

J Pharmacol Exp Ther. 2009 Dec;331(3):796-807. doi: 10.1124/jpet.109.156646. Epub 2009 Sep 15.

29.

Green tea polyphenols ameliorate pancreatic injury in cerulein-induced murine acute pancreatitis.

Babu BI, Malleo G, Genovese T, Mazzon E, Di Paola R, Crisafulli C, Caminiti R, Siriwardena AK, Cuzzocrea S.

Pancreas. 2009 Nov;38(8):954-67. doi: 10.1097/MPA.0b013e3181b28d11.

PMID:
19672210
30.

The P2Y-like receptor GPR17 as a sensor of damage and a new potential target in spinal cord injury.

Ceruti S, Villa G, Genovese T, Mazzon E, Longhi R, Rosa P, Bramanti P, Cuzzocrea S, Abbracchio MP.

Brain. 2009 Aug;132(Pt 8):2206-18. doi: 10.1093/brain/awp147. Epub 2009 Jun 15.

PMID:
19528093
31.

Protective effect of melatonin against the inflammatory response elicited by crude venom from isolated nematocysts of Pelagia noctiluca (Cnidaria, Scyphozoa).

Marino A, Di Paola R, Crisafulli C, Mazzon E, Morabito R, Paterniti I, Galuppo M, Genovese T, La Spada G, Cuzzocrea S.

J Pineal Res. 2009 Aug;47(1):56-69. doi: 10.1111/j.1600-079X.2009.00688.x. Epub 2009 May 27.

PMID:
19486271
32.

Effects of a metalloporphyrinic peroxynitrite decomposition catalyst, ww-85, in a mouse model of spinal cord injury.

Genovese T, Mazzon E, Esposito E, Di Paola R, Murthy K, Neville L, Bramanti P, Cuzzocrea S.

Free Radic Res. 2009 Jul;43(7):631-45. doi: 10.1080/10715760902954126.

PMID:
19418318
33.

PPAR-alpha modulate the anti-inflammatory effect of glucocorticoids in the secondary damage in experimental spinal cord trauma.

Genovese T, Esposito E, Mazzon E, Crisafulli C, Paterniti I, Di Paola R, Galuppo M, Bramanti P, Cuzzocrea S.

Pharmacol Res. 2009 May;59(5):338-50. doi: 10.1016/j.phrs.2009.01.018. Epub 2009 Feb 13.

PMID:
19416634
34.

Treatment with green tea extract attenuates secondary inflammatory response in an experimental model of spinal cord trauma.

Paterniti I, Genovese T, Crisafulli C, Mazzon E, Di Paola R, Galuppo M, Bramanti P, Cuzzocrea S.

Naunyn Schmiedebergs Arch Pharmacol. 2009 Aug;380(2):179-92. doi: 10.1007/s00210-009-0414-z. Epub 2009 Apr 1.

35.

The selective adenosine A2A receptor agonist CGS 21680 reduces JNK MAPK activation in oligodendrocytes in injured spinal cord.

Genovese T, Melani A, Esposito E, Mazzon E, Di Paola R, Bramanti P, Pedata F, Cuzzocrea S.

Shock. 2009 Dec;32(6):578-85. doi: 10.1097/SHK.0b013e3181a20792.

PMID:
19295488
36.

Absence of endogenous interleukin-10 enhances secondary inflammatory process after spinal cord compression injury in mice.

Genovese T, Esposito E, Mazzon E, Di Paola R, Caminiti R, Bramanti P, Cappelani A, Cuzzocrea S.

J Neurochem. 2009 Mar;108(6):1360-72. doi: 10.1111/j.1471-4159.2009.05899.x. Epub 2009 Jan 22.

37.

Melatonin reduces stress-activated/mitogen-activated protein kinases in spinal cord injury.

Esposito E, Genovese T, Caminiti R, Bramanti P, Meli R, Cuzzocrea S.

J Pineal Res. 2009 Jan;46(1):79-86. doi: 10.1111/j.1600-079X.2008.00633.x.

PMID:
19090911
38.

16,16-Dimethyl prostaglandin E2 efficacy on prevention and protection from bleomycin-induced lung injury and fibrosis.

Failla M, Genovese T, Mazzon E, Fruciano M, Fagone E, Gili E, Barera A, La Rosa C, Conte E, Crimi N, Cuzzocrea S, Vancheri C.

Am J Respir Cell Mol Biol. 2009 Jul;41(1):50-8. doi: 10.1165/rcmb.2007-0438OC. Epub 2008 Dec 4.

PMID:
19059888
39.

Myrtucommulone from Myrtus communis exhibits potent anti-inflammatory effectiveness in vivo.

Rossi A, Di Paola R, Mazzon E, Genovese T, Caminiti R, Bramanti P, Pergola C, Koeberle A, Werz O, Sautebin L, Cuzzocrea S.

J Pharmacol Exp Ther. 2009 Apr;329(1):76-86. doi: 10.1124/jpet.108.143214. Epub 2008 Dec 4.

40.

Ethyl pyruvate reduces the development of zymosan-induced generalized inflammation in mice.

Di Paola R, Mazzon E, Genovese T, Crisafulli C, Bramanti P, Caminiti R, Esposito E, Fink MP, Cuzzocrea S.

Crit Care Med. 2009 Jan;37(1):270-82. doi: 10.1097/CCM.0b013e318192fa63.

PMID:
19050619
41.

Protective effects of glycyrrhizin in a gut hypoxia (ischemia)-reoxygenation (reperfusion) model.

Di Paola R, Menegazzi M, Mazzon E, Genovese T, Crisafulli C, Dal Bosco M, Zou Z, Suzuki H, Cuzzocrea S.

Intensive Care Med. 2009 Apr;35(4):687-97. doi: 10.1007/s00134-008-1334-y. Epub 2008 Oct 25.

PMID:
18953525
42.

Beneficial effects of ethyl pyruvate in a mouse model of spinal cord injury.

Genovese T, Esposito E, Mazzon E, Di Paola R, Meli R, Caminiti R, Bramanti P, Fink MP, Cuzzocrea S.

Shock. 2009 Aug;32(2):217-27. doi: 10.1097/SHK.0b013e31818d4073.

PMID:
18948848
43.

Inhibition of ceramide biosynthesis ameliorates pathological consequences of spinal cord injury.

Cuzzocrea S, Deigner HP, Genovese T, Mazzon E, Esposito E, Crisafulli C, Di Paola R, Bramanti P, Matuschak G, Salvemini D.

Shock. 2009 Jun;31(6):634-44. doi: 10.1097/SHK.0b013e3181891396.

PMID:
18838947
44.

Glycyrrhizin reduces secondary inflammatory process after spinal cord compression injury in mice.

Genovese T, Menegazzi M, Mazzon E, Crisafulli C, Di Paola R, Dal Bosco M, Zou Z, Suzuki H, Cuzzocrea S.

Shock. 2009 Apr;31(4):367-75. doi: 10.1097/SHK.0b013e3181833b08.

PMID:
18665052
45.

Fumonisin b1 reduces the development of multiple organ failure induced by zymosan in mice.

Cuzzocrea S, Genovese T, Mazzon E, Esposito E, Crisafulli C, Di Paola R, Bramanti P, Salvemini D.

Shock. 2009 Feb;31(2):170-7. doi: 10.1097/SHK.0b013e31817fbd4a.

PMID:
18650782
46.

Effect of cyclopentanone prostaglandin 15-deoxy-delta12,14PGJ2 on early functional recovery from experimental spinal cord injury.

Genovese T, Esposito E, Mazzon E, Di Paola R, Muià C, Meli R, Bramanti P, Cuzzocrea S.

Shock. 2008 Aug;30(2):142-52. doi: 10.1097/SHK.0b013e31815dd381.

PMID:
18628687
47.

Anti-inflammatory and anti-apoptotic effects of fumonisin B1, an inhibitor of ceramide synthase, in a rodent model of splanchnic ischemia and reperfusion injury.

Cuzzocrea S, Di Paola R, Genovese T, Mazzon E, Esposito E, Crisafulli C, Bramanti P, Salvemini D.

J Pharmacol Exp Ther. 2008 Oct;327(1):45-57. doi: 10.1124/jpet.108.139808. Epub 2008 Jul 8.

48.

Glycyrrhizin attenuates the development of carrageenan-induced lung injury in mice.

Menegazzi M, Di Paola R, Mazzon E, Genovese T, Crisafulli C, Dal Bosco M, Zou Z, Suzuki H, Cuzzocrea S.

Pharmacol Res. 2008 Jul;58(1):22-31. doi: 10.1016/j.phrs.2008.05.012. Epub 2008 Jun 11.

PMID:
18590825
49.

Effect of tumour necrosis factor-alpha receptor 1 genetic deletion on carrageenan-induced acute inflammation: a comparison with etanercept.

Mazzon E, Esposito E, Di Paola R, Muià C, Crisafulli C, Genovese T, Caminiti R, Meli R, Bramanti P, Cuzzocrea S.

Clin Exp Immunol. 2008 Jul;153(1):136-49. doi: 10.1111/j.1365-2249.2008.03669.x. Epub 2008 May 26.

50.

Effects of palmitoylethanolamide on signaling pathways implicated in the development of spinal cord injury.

Genovese T, Esposito E, Mazzon E, Di Paola R, Meli R, Bramanti P, Piomelli D, Calignano A, Cuzzocrea S.

J Pharmacol Exp Ther. 2008 Jul;326(1):12-23. doi: 10.1124/jpet.108.136903. Epub 2008 Mar 26.

Supplemental Content

Loading ...
Support Center